Pyoderma gangrenosum: A review and update on new therapies
作者： Jeremiah Miller , Brad A. Yentzer , Adele Clark , Joseph L. Jorizzo , Steven R. Feldman
DOI: 10.1016/J.JAAD.2009.05.030
关键词:
摘要: … Side effects of IVIG reported include nausea and headache and one report of aseptic … Although one patient stopped therapy because of the side effect of cacogeusia, all 7 cases of PG …
jaad.org
elsevier.com
sci-hub.se 参考文章(60)
Pestarino A, Gambini C, Massone L, Borghi S, Topical disodium cromoglycate in the management of pyoderma gangrenosum. Cutis. ,vol. 42, pp. 459- 462 ,(1988)
Grant J Anhalt, Margaret A Fonder, Jon H Meyerle, Deborah L Cummins, Benjamin D Ehst, Adalimumab therapy for recalcitrant pyoderma gangrenosum. ePlasty. ,vol. 5, ,(2006)
Topical tacrolimus for pyoderma gangrenosum : Another report Journal of Dermatology. ,vol. 33, pp. 232- 232 ,(2006) , 10.1111/J.1346-8138.2006.00055.X
Joerg Wenzel, Rainer Gerdsen, Wolfgang Phillipp-Dormston, Thomas Bieber, Manfred Uerlich, Topical Treatment of Pyoderma gangraenosum Dermatology. ,vol. 205, pp. 221- 223 ,(2002) , 10.1159/000065843
R.G. Pomerantz, M.E. Husni, E. Mody, A.A. Qureshi, Adalimumab for treatment of pyoderma gangrenosum. British Journal of Dermatology. ,vol. 157, pp. 1274- 1275 ,(2007) , 10.1111/J.1365-2133.2007.08212.X
CE Foss, AR Clark, R Inabinet, F Camacho, JL Jorizzo, An open-label pilot study of alefacept for the treatment of pyoderma gangrenosum Journal of The European Academy of Dermatology and Venereology. ,vol. 22, pp. 943- 949 ,(2008) , 10.1111/J.1468-3083.2008.02680.X
Pascal Juillerat, Stephanie Christen-Zäch, François-Xavier Troillet, Suzanne Gallot-Lavallée, Renato G. Pannizzon, Pierre Michetti, Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review. Dermatology. ,vol. 215, pp. 245- 251 ,(2007) , 10.1159/000106584
L. Jenne, B. Sauter, P. Thumann, M. Hertl, G. Schuler, Successful treatment of therapy‐resistant chronic vegetating pyoderma gangrenosum with infliximab (chimeric antitumour necrosis factor antibody) British Journal of Dermatology. ,vol. 150, pp. 380- 382 ,(2004) , 10.1111/J.1365-2133.2003.05760.X
Faruk Hadziselimovic, Adalimumab induces and maintains remission in severe, resistant paediatric Crohn disease. Journal of Pediatric Gastroenterology and Nutrition. ,vol. 46, pp. 208- 211 ,(2008) , 10.1097/MPG.0B013E318124504B
Ilana Kaufman, Dan Caspi, Dror Yeshurun, Iris Dotan, Michael Yaron, Ori Elkayam, The effect of infliximab on extraintestinal manifestations of Crohn's disease. Rheumatology International. ,vol. 25, pp. 406- 410 ,(2005) , 10.1007/S00296-004-0467-8